Mitochondrial Adenosine Triphosphate–regulated Potassium Channel Opening Acts as a Trigger for Isoflurane-induced Preconditioning by Generating Reactive Oxygen Species

  • Katsuya Tanaka
    Research Fellow.
  • Dorothee Weihrauch
    Assistant Professor.
  • Lynda M. Ludwig
    Graduate Student.
  • Judy R. Kersten
    Professor, Departments of Anesthesiology and Pharmacology and Toxicology.
  • Paul S. Pagel
    Professor and Director of Cardiac Anesthesia, Departments of Anesthesiology and Pharmacology and Toxicology, Division of Cardiovascular Diseases, Department of Medicine.
  • David C. Warltier
    Professor, Departments of Anesthesiology and Pharmacology and Toxicology, Department of Medicine, Division of Cardiovascular Diseases, and Vice Chairman for Research, Department of Anesthesiology.

抄録

<jats:sec> <jats:title>Background</jats:title> <jats:p>Whether the opening of mitochondrial adenosine triphosphate-regulated potassium (K(ATP)) channels is a trigger or an end effector of anesthetic-induced preconditioning is unknown. We tested the hypothesis that the opening of mitochondrial K(ATP) channels triggers isoflurane-induced preconditioning by generating reactive oxygen species (ROS) in vivo.</jats:p> </jats:sec> <jats:sec> <jats:title>Methods</jats:title> <jats:p>Pentobarbital-anesthetized rabbits were subjected to a 30-min coronary artery occlusion followed by 3 h reperfusion. Rabbits were randomly assigned to receive a vehicle (0.9% saline) or the selective mitochondrial K(ATP) channel blocker 5-hydroxydecanoate (5-HD) alone 10 min before or immediately after a 30-min exposure to 1.0 minimum alveolar concentration (MAC) isoflurane. In another series of experiments, the fluorescent probe dihydroethidium was used to assess superoxide anion production during administration of 5-HD or the ROS scavengers N-acetylcysteine or N-2-mercaptopropionyl glycine (2-MPG) in the presence or absence of 1.0 MAC isoflurane. Myocardial infarct size and superoxide anion production were measured using triphenyltetrazolium staining and confocal fluorescence microscopy, respectively.</jats:p> </jats:sec> <jats:sec> <jats:title>Results</jats:title> <jats:p>Isoflurane (P &lt; 0.05) decreased infarct size to 19 +/- 3% (mean +/- SEM) of the left ventricular area at risk as compared to the control (38 +/- 4%). 5-HD administered before but not after isoflurane abolished this beneficial effect (37 +/- 4% as compared to 24 +/- 3%). 5-HD alone had no effect on infarct size (42 +/- 3%). Isoflurane increased fluorescence intensity. Pretreatment with N-acetylcysteine, 2-MPG, or 5-HD before isoflurane abolished increases in fluorescence, but administration of 5-HD after isoflurane only partially attenuated increases in fluorescence produced by the volatile anesthetic agent.</jats:p> </jats:sec> <jats:sec> <jats:title>Conclusions</jats:title> <jats:p>The results indicate that mitochondrial K(ATP) channel opening acts as a trigger for isoflurane-induced preconditioning by generating ROS in vivo.</jats:p> </jats:sec>

収録刊行物

  • Anesthesiology

    Anesthesiology 98 (4), 935-943, 2003-04-01

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (7)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ